Description
ITPP + SR-9011 Tablets
ITPP + SR-9011 tablets are researched in lab settings for their potential to regulate different pathways. Researchers use this stack to explore its possible effects on stamina, endurance, cellular energy, and metabolism in different research settings.
Formulation Details:
Each tablet contains 50 mg ITPP + 20 mg SR-9011 (Total: 70 mg per tablet)
Available Counts:
- 27 tablets (1890 mg total)
- 54 tablets (3780 mg total)
Overview of ITPP Tablets
ITPP, also known as Myo-Inositol Trispyrophosphate, is a synthetic allosteric effector of hemoglobin. In different research models, ITPP has been shown to increase oxygen release from red blood cells. By doing so, ITPP may help oxygen delivery to tissues under hypoxic conditions (low oxygen).
Preliminary studies have shown that by doing this, the compound may improve endurance, delay fatigue, and support cardiovascular function.
Researchers have also explored its possible role in ischemia or tumor hypoxia, though findings remain limited. So more research is required!
Overview of SR-9011 Tablets
SR-9011 is structurally related to SR-9009 and belongs to the class of Rev-Erb agonists. Experimental studies have observed that SR-9011 may influence glucose metabolism, increase energy expenditure, and reduce fat accumulation in lab settings.
Working Mechanism of ITPP + SR-9011 Tablets
Both ITPP and SR-9011 work differently under various research environments. Here is the breakdown of their working mechanism:
ITPP Tablets
Researchers have observed that ITPP may work by modulating hemoglobin. Hemoglobin is believed to increase oxygen release from red blood cells in various research models. In research settings, it may alter the structure of hemoglobin to ease the delivery of oxygen smoothly in low-oxygen tissues.
Studies suggest ITPP may also support cellular metabolism as observed in research subjects. The process is carried out when ITPP optimizes oxygen-dependent energy pathways in experimental models.
| Myo-inositol Trispyrophosphate (ITPP) | |
| CAS Number | 23103-35-7 |
| Molar Mass | 605.98 g/mol |
| Chemical Formula | C6H12O21P6 |
| IUPAC Name | [[(2R,3R,4R,5R)-6-(dihydrogen phosphate)-3,4,5-trihydroxyoxan-2-yl]methyl] bis(dihydrogen diphosphate) |
SR-9011 Tablets
Researchers have found from lab studies that SR-9011 may work by binding to Rev-Erb receptors in cells. A Rev-Erb agonist is a compound that may activate a nuclear receptor known as Rev-Erbα. The Rev-Erbα receptor protein is found in the cells, as studied in different research subjects.
The binding may trigger the receptor, which then represses certain genes as observed in preclinical models. These genes are believed to control the production of proteins involved in metabolism and sleep-wake cycles in research subjects.
| SR 9011 | |
| CAS Number | 1379686-29-9 |
| Molar Mass | 479.04 g/mol |
| Chemical Formula | C23H31ClN4O3S |
| IUPAC Name | 3-[[(4-chlorophenyl)methyl-[(5-nitrothiophen-2-yl)methyl]amino]methyl]-N-pentylpyrrolidine-1-carboxamide |
Combined Effects of ITPP + SR-9011 Tablets
Researchers have closely observed in different laboratory settings that the combination of ITPP and SR-9011 may possess synergistic effects. These effects have been shown to potentially improve cellular energy, boost metabolic rate, and energy utilization in research subjects.
Potential Benefits | ITPP
Here are the potential benefits of ITPP as shown in preclinical models. These benefits are studied in various research settings and not in humans.
- Improves oxygen delivery to tissues in research subjects.
- Enhances endurance and exercise performance in research models.
- Increases oxygen utilization efficiency in research subjects.
- Supports muscle energy metabolism in research models.
- May reduce fatigue in research subjects.
- Improves hypoxia tolerance in research models.
Potential Side Effects | ITPP
The following are a few side effects observed in research subjects. However, long-term research is required to understand the full safety profile of this compound.
- Risk of altered oxygen saturation in research models.
- Potential electrolyte imbalance in research models.
- Risk of increased oxidative stress in research subjects.
- Possible mild gastrointestinal discomfort in research models.
Potential Benefits | SR-9011
Below are the potential benefits of SR-9011 as shown in preclinical models. These benefits are studied in various research settings and not in humans.
- May enhance endurance in experimental models
- May increase metabolic rate in lab studies
- May improve lipid and glucose metabolism in experimental models
- May regulate circadian rhythm in preliminary studies
- May have anti-obesity effects in experimental models
- May optimize cellular energy in experimental models
Potential Side Effects | SR-9011
The following are the side effects observed in research subjects. However, long-term research is required to understand the full safety profile of this compound.
- May disrupt sleep patterns in experimental models
- May cause fatigue in experimental models
- May affect appetite regulation in preliminary studies
- May induce mild liver enzyme changes in experimental models
- May increase heart rate in experimental models
Where to Buy the ITPP + SR-9011 Tablets?
You can buy ITPP + SR-9011 tablets directly from our online shop. At Purerawz, we offer you reliable and authentic ITPP + SR-9011 for research purposes. We also have a certificate of analysis (COA) of these compounds. Plus, the compounds are third-party verified. All these things ensure you have a safe experience.
Disclaimer:
This information is for educational purposes only and not medical advice. Products are for research use only. Research must follow IRB or IACUC guidelines. Verify information independently before purchasing. By ordering, you agree to our Terms and Conditions.
ATTENTION: All our products are for LABORATORY AND RESEARCH PURPOSES ONLY, not for veterinary or human use.
Reviews
There are no reviews yet.